Tampon

DEVICE4 trials

Sponsors

Bayer, TherapeuticsMD, Uniformed Services University of the Health Sciences, Lyv Life Inc. (dba: Cora)

Conditions

ContraceptionEndometriosisSafety and Tolerability in Healthy Volunteers

Phase 1

Effect of Concomitant Use of an Antimycotic, an Antibiotic, a Spermicide or Tampons on Pharmacokinetics of Anastrozole and Levonorgestrel Released From Intra-vaginal Ring

CompletedNCT02545452

BayerEndometriosis

Start: 2015-09-15End: 2016-07-29Updated: 2017-07-24

The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

CompletedNCT04272008

TherapeuticsMDContraception

Start: 2020-03-06End: 2021-06-08Updated: 2021-10-29

Phase 4

Patient-Applied Pretreatment Analgesia for Intrauterine Device Placement

Uniformed Services University of the Health SciencesContraception

Start: 2023-06-30End: 2024-01-31Target: 120Updated: 2023-06-06

Unknown Phase

Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon

RecruitingNCT07807891

Lyv Life Inc. (dba: Cora)Safety and Tolerability in Healthy Volunteers

Start: 2026-09-10End: 2027-04-30Target: 120Updated: 2026-09-08